1. Arrival and Admission
Upon arrival at our affiliated hospital in western Poland, patients are welcomed into a modern, comfortable facility.
Upon arrival at our affiliated hospital in western Poland, patients are welcomed into a modern, comfortable facility.
The patient undergoes routine bloodwork, a comprehensive history, and a physical examination. An anesthesiologist evaluates the patient for medical clearance for the planned procedures.
Once medically cleared, a small muscle sample is obtained via a minimally invasive procedure. The donor—typically the patient's father—is biopsied the same way.
The samples are shipped to our certified GMP facility where chimeric myoblasts are manufactured using a proprietary process. This process takes approximately 45 days.
Once the cells are ready, the patient returns to the hospital. After confirming medical fitness, the chimeric cells are injected with a small needle directly into the bone marrow compartment.
The Chimeric Medicine Institute is committed to safe, ethical, science-based care delivered in a regulated hospital setting with European compliance standards. For a list of pre-clinical and clinical publications please click on this link.
If your family is seeking advanced access options, please:
All inquiries are confidential. No treatments are administered without medical clearance and approval by a certified ethics committee.
Managed by Dystrogen Therapeutics Technology Polska sp. z o.o.
Warsaw Corporate Center
ul. Emilii Plater 28
00-688 Warszawa